ESR1 and breast cancer: evaluated CD47 expression using immunohistochemistry and observed that CD47 expression in breast cancer samples was significantly associated with advanced tumor node metastasis (TNM) stage, histological grade, estrogen receptor (ER) status, progesterone receptor (PR) status, and recurrence.